Skip to main content

The Transformative Vision of Dr. Robert Uzzo

Robert Uzzo, MD, MBA, FACS, is a visionary surgeon, researcher, innovator, and leader, qualities evident when he first joined Fox Chase after completing his fellowship training in 2000, all of which led to his appointment as new President and CEO of Fox Chase Cancer Center.

“Dr.

Dr. Uzzo

Before he was appointed President and CEO, Dr. Uzzo was a former Chair of Fox Chase Cancer Center’s Department of Surgery and one of the principal architects of Fox Chase Cancer Center’s nationally recognized urology program. In addition, Dr. Uzzo has guided significant clinical growth through the integration and collaboration of Fox Chase Cancer Center with the Temple Health System.

"Dr. Uzzo has made us his professional home. He has built a stellar career with achievements that have advanced the care of patients with urologic cancers and the clinical offerings and reputation of the institution itself,” says Michael A. Young, MHA, FACHE, President and CEO of the Temple University Health System.

Fellowship-trained in laparoscopic and robotic surgery, Dr. Uzzo is an expert in nerve-sparing, organ-sparing, and reconstructive organ surgery for men and women. "Preserving normal function is a sensitive issue that accompanies genitourinary cancer surgery and has a physical and emotional impact on patients and their families," explains Dr. Uzzo.

Dr. Uzzo empowers patients to be the managers of their care. "Dr. Uzzo's compassionate approach endears him to those who have chosen Fox Chase Cancer Center to guide them on their cancer journey," Young added.

As a researcher and innovator, Dr. Uzzo is renowned for urologic cancer advancements, serving as the primary investigator and co-investigator in numerous clinical trials. His focus is primarily on renal cell carcinoma, with a unique lens on clinical decision-making, surgical management, and adjuvant therapies. In addition, he is the developer of the R.E.N.A.L. Nephrometry Scoring System—the first and most widely used system to delineate the complexity of renal tumors and the impact of care.

Dr. Uzzo has lectured regionally, nationally, and internationally on kidney, prostate, bladder, and testicular cancer and has published more than 500 urologic oncology journal papers. He has earned the great respect of his peers—recognized as a Philadelphia magazine Top Doctor since 2002.

Dr. Uzzo brings a fiery determination to 'double down on cancer' by advancing scientific discovery within the great institutions of Fox Chase Cancer Center and Temple Health and fostering collaboration with the best research minds worldwide. A discovery that ultimately delivers a cure for cancer and transforms how we live.